Emergency Department Treatment of Opioid Use Disorder

September 7, 2022

The United States continues to face an unprecedented crisis of overdose deaths with a more than 30% increase over the last 2 years. A coordinated, multi-faceted approach to patient care is needed to support our patients and reduce the risk of death associated with drug use, particularly opioid use. The emergency department has continued to play a pivotal role in identifying patients at risk of overdose death and initiating evidence-based substance use treatment. The body of evidence and regulatory environment continues to evolve necessitating provider education to fully capitalize on existing resources and treatment strategies.

Target Audience

Emergency Physicians, Advanced Practice Providers, and Pharmacists.

Learning Objectives

• Provide updated stats and trends regarding substance use and overdose deaths
• Review screening opportunities in emergency medicine
• Discuss updates in harm reduction opportunities
• Present updated evidence guiding initiation of medication management of opioid use disorder, specifically buprenorphine
• Review buprenorphine prescribing practices
• Review warm handoff processes for follow up care including telemedicine

Additional Information

AttachmentSize
PDF icon Webinar Announcement (003).pdf157.89 KB
Course summary
Available credit: 
  • 2.00 AAPA Category I CME
    • 2.00 Opioid Education
  • 2.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 2.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
    • 2.00 Opioid Education
  • 2.00 Attendance
    • 2.00 Opioid Education
Course opens: 
08/09/2022
Course expires: 
12/31/2022
Event starts: 
09/07/2022 - 9:00am EDT
Event ends: 
09/07/2022 - 11:00am EDT
Add to calendar: 

Agenda:
Speaker: Michael Lynch, MD FACMT

9-9:05 Introduction

9:05-9:30  
• Provide updated stats and trends regarding substance use and overdose deaths 
• Review screening opportunities in emergency medicine 
• Discuss updates in harm reduction opportunities

9:30-9:40  Concept Summary and Review with Q&A

9:40-10:20
• Present updated evidence guiding initiation of medication management of opioid use disorder, specifically buprenorphine
• Review buprenorphine prescribing practices

10:20-10:30  Concept Summary and Review with Q&A

10:30-10:50 
• Review warm handoff processes for follow up care including telemedicine

10:50-11:00 Conclusion, Discussion and Adjournment

Live Virtual Conference

Speaker: Dr. Michael Lynch, MD FACMT
Medical Director, PA Department of Drug and Alcohol Programs
Associate Professor of Emergency Medicine, Medical Toxicology, and Addiction Medicine
Medical Director of Substance Use Disorder Services, UPMC Health Plan

Faculty Disclosure:  
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy (CPE)
This knowledge-based activity provides 2.0 contact hours of continuing pharmacy education credit.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 


This activity is approved for the following credit: AMA PRA Category 1 Credit™, ACPE, and AAPA Category 1 CME. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 2.00 AAPA Category I CME
    • 2.00 Opioid Education
  • 2.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 2.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
    • 2.00 Opioid Education
  • 2.00 Attendance
    • 2.00 Opioid Education
Please login or register to take this course.

Registration is required.

Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by emailing (lyncmj@upmc.edu)

For more information, please contact Michael Lynch by email at lyncmj@upmc.edu.